Malignant aldosterone-producing adrenal tumour: Reoccurrence with glucocorticoid excess without hyperaldosteronism

Netherlands Journal of Medicine

Volumn 66, Issue 6, 2008, Pages 252-255

  Abma, E M ^a   Kluin, P M ^a   Dullaart, R P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Adrenal carcinoma; Aldosterone; Hypertension; Hypokalaemia

Indexed keywords

ALDOSTERONE; ANDROGEN; CORTICOTROPIN; CORTODOXONE; GLUCOCORTICOID; GLUCURONIDE; HYDROCORTISONE; MITOTANE; POTASSIUM; RENIN; TESTOSTERONE;

ADRENAL TUMOR; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; ASCITES; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; FEMALE; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERALDOSTERONISM; HYPERKALEMIA; HYPERTENSION; KIDNEY METASTASIS; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA RENIN ACTIVITY; SALT LOADING; URINARY EXCRETION; URINE LEVEL;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; BLOOD PRESSURE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDROCORTISONE; HYPERALDOSTERONISM; HYPERKALEMIA; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POTASSIUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 46649109401     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mattsson C, Young WF Jr. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephr 2006;2:198-208.
2. Allolio B, Fassnacht M. Clinical review: Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006;91:2027-37.
3. Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urology 2003;169:5-11.
4. Paton BL, Novitsky YW, Zerey M, et al. Outcomes of adrenal cortical carcinoma in the United States. Surgery 2006;140:914-20.
5. Kebebew E, Reiff E, Duh QY, et al. Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress? World J Surg 2006;30:872-8.
6. Seccia TM, Fassina A, Nussdorfer GG, et al. Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. Endocrine-Related Cancer 2005;12:149-59.
7. Gicquel C, Bertagna X, Gaston V, et al. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors. Cancer Res 2001;6:6762-7.
8. Barzon L, Fallo F, Sonino N, et al. Adrenocortical carcinoma: experience in 45 patients. Oncology 1997;54:490-6.
9. Arteaga E, Biglieri EG, Kater CE, et al. Aldosterone-producing adrenocortical carcinoma. Preoperative recognition and course in three cases. Ann Int Med 1984;101:316-21.
10. Hisamatsu H, Sakai H, Irie J, et al. Adrenocortical carcinoma with primary aldosteronism associated with Cushing syndrome during recurrence. BJU Int 2002;90:971-2.
11. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984;8:163-9.
12. Aubert S, Wacrenier A, Leroy X, et al. Weiss System Revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Path 2002;26:1612-9.
13. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consens State Sci Statements 2002;19(2):1-25.
14. Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990;322:1195-201.
15. McNicholas MM, Lee MJ, Mayo-Smith WW, Hahn PF, Boland GW, Mueller PR. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR 1995;165:1453-9.